Related Experiment Video
Updated: Nov 8, 2025

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
Published on: February 24, 2023
Abstract:
The first comprehensive catalog of genetic vulnerabilities in pediatric tumors has identified dozens of potential new therapeutic targets, mostly in genes not known to harbor activating mutations-many unique to childhood cancers. The findings, part of the Cancer Dependency Map Project, reveal that pediatric cancers, despite their lower mutational burden relative to adult tumors, harbor just as many genes that cancer cells rely upon for growth and survival.
Insights
A new catalog reveals genetic vulnerabilities in pediatric tumors, identifying new therapeutic targets unique to childhood cancers. These findings show pediatric cancers rely on specific genes for survival, similar to adult tumors.
Area of Science:
- Oncology
- Genetics
- Cancer Biology
Background:
- Pediatric tumors present unique genetic landscapes compared to adult malignancies.
- Understanding genetic dependencies is crucial for developing targeted cancer therapies.
- The Cancer Dependency Map Project aims to comprehensively map cancer vulnerabilities.
Purpose of the Study:
- To create the first comprehensive catalog of genetic vulnerabilities in pediatric tumors.
- To identify novel therapeutic targets for childhood cancers.
- To compare the genetic dependencies of pediatric and adult tumors.
Main Methods:
- Systematic screening for genetic dependencies across a wide range of pediatric tumor types.
- Analysis of gene expression and mutation data to identify essential genes.
- Comparison of identified vulnerabilities with known cancer gene databases.
Main Results:
- Identification of dozens of potential therapeutic targets in pediatric cancers.
- Discovery of vulnerabilities in genes not previously known to harbor activating mutations.
- Many identified vulnerabilities are unique to childhood cancers.
- Pediatric tumors, despite lower mutational burden, exhibit a similar number of essential gene dependencies as adult tumors.
Conclusions:
- The comprehensive catalog provides a valuable resource for pediatric cancer research.
- New therapeutic strategies targeting identified genetic vulnerabilities can be explored.
- Targeting unique genetic dependencies may overcome resistance in childhood cancers.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer

